Delivery Order SPE2DX22D0010-SPE2D826FAS13
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of methylphenidate extended-release 54 mg tablets (100-count packages) at a ceiling value of $1,211.52. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate Extended Release 54 mg tablets (100-count) with a firm fixed price ceiling value of $1,097.52. The contract, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive award under the company's broader pharmaceutical supply vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36mg tablets (100-count) with a ceiling value of $5,179.68. This non-competitive, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of the same day. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Methylphenidate ER (extended-release) brand-name tablets at 72mg strength. This firm fixed-price delivery order is valued at $6,334.55 with an ultimate completion date of November 3, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, with performance taking place at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER tablets 54 mg on October 2, 2025, with a firm fixed price contract value of $1,221.15 and an ultimate completion date of October 3, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement to support federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Methylphenidate Extended Release 36mg tablets (100 count) with a ceiling value of $3,248.16 under a firm fixed-price contract type. The award was issued on August 11, 2025, with an ultimate completion date of the same day, and represents a non-set-aside, competitively awarded procurement from the Defense Logistics Agency's Medical Supply Chain. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $4,382.80. This competitively awarded, firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order valued at $2,884.88 to AmerisourceBergen Drug Corp for Methylphenidate Extended-Release 36 mg tablets (100-count supply). This firm fixed-price delivery order, issued on August 19, 2025, with completion targeted for August 20, 2025, represents a competitively awarded contract with no set-aside designation. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAS13Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate extended-release tablets (54mg) with a ceiling value of $6,043.30. This is a firm fixed-price delivery order issued on October 29, 2025, with an ultimate completion date of October 30, 2025. The award carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the Defense Logistics Agency. The company maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated extensive capability in fulfilling federal medical procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations through competitive award mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 10/29/25 |